Tracheal intubation conditions after one minute: Rocuronium and vecuronium, alone and in combination

Anaesthesia

Volumn 52, Issue 4, 1997, Pages 336-340

  England, A J ^a   Margarson, M P ^b   Feldman, S A ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Intubation; tracheal; Neuromuscular relaxants; vecuronium, rocuronium

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; VECURONIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENTIATION; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030935796     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.103-az0100.x     Document Type: Article

References (27)

1. Puhringer FK, Khuenl-Bnidy KS, Koller J, Mitterschiffthaler G. Evaluation of the endotracheal intubating conditions of rocuronium (Org 9426) and succinylcholine in outpatient surgery. Anesthesia and Analgesia 1992; 75: 37-40.
2. Huizinga AC, Vandenbrom RH, Wierda JM, Hommes FD. Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426); a comparison with suxamethonium. Acta Anaesthesiologica Scandinavica 1992; 36: 463-8.
3. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z. Comparison of intubating conditions after administration of Org 9426 (rocuronium) and suxamethonium. British Journal of Anaesthesia 1992; 69: 269-93.
4. Abouleish E, Abboud T, Lechevalier T, Zhu J, Alford K. Rocuronium (Org 9426) for caesarean section. British Journal of Anaesthesia 1994; 73: 336-41.
5. Naguib M. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Anesthesiology 1994; 81: 388-95.
6. Kim SY, Cho MH. Neuromuscular and cardiovascular advantages of combinations of mivacurium and rocuronium over either drug alone. Anaesthesia 1996; 51: 929-31.
7. Wierda JM, De Wit AP, Kuizenga K, Agoston S. Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarising agent. British Journal of Anaesthesia 1990; 64: 521-3.
8. Nagashima H, Yun H, Radnay PA, Duncalf D, Kaplan R, Foldes FF. Influence of anaesthesia on human dose- response of Org-NC45. Anesthesiology 1981; 55: A202.
9. Goldberg ME, Larijani GE, Azad SS et al. Comparison of tracheal intubation conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients. Anesthesia and Analgesia 1989; 69: 93-9.
10. Bartkowski RR, Witkowski TA, Azad S, Lessin J, Marr A. Rocuronium onset of action: a comparison with atracurium and vecuronium. Anesthesia and Analgesia 1993; 77: 574-8.
11. Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinycholine and vecuronium for rapid sequence induction of anesthesia in adult patients. Anesthesiology 1993; 79: 913-8.
12. Mayer M, Doenicke A, Hofmann A, Peter K. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia. British Journal of Anaesthesia 1992; 69: 511-2.
13. Booth MG, Marsh B, Bryden FM, Robertson EN, Baird WLM. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992; 47: 832-4.
14. Redai I, Feldman SA. Priming studies with rocuronium and vecuronium. European Journal of Anaesthesiology 1995; 12: 11-13.
15. Redai I, Haxby E. Priming, rocuronium and mivacurium. Anaesthetic Pharmacology Review 1995; 3: 209-11.
16. Foldes FF, Nagashinu H, Nguyen H, Ohta Y. The clinical pharmacology of Org9426. In: Bowman WC, Denissen PAF, Feldman S, eds. Neuromuscular Blocking Agents: Past, Present and Future. Amsterdam: Exerpta Medica, 1990: 171-81.
17. Naguib M, Abdulatif M. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium. British Journal of Anaesthesia 1993; 71: 556-60.
18. England A. Rocuronium and the onset/offset paradox. Anaesthetic Pharmacology Review 1995; 3: 212-7.
19. Nigrovic V, Marovic, V, Mellinghoff H, Buzello W. Modelling the interaction of two neuromuscular blocking agents: generation of an additive or a supraadditive neuromuscular block. British Journal of Anaesthesia 1996; 76: 580-1.
20. Feldman SA, Wu X, England AJ. Rate of 'onset' and 'offset' of four nondepolarising neuromuscular blocking drugs. Anaesthesia 1995; 50: 510-3.
21. England AJ, Pannikar K, Redai I, Haxby E, Gopinath S, Feldman SA. Is rocuronium an exception to the onset-offset relationship? A comparison with pipecuronium. European Journal of Anaesthesia 1996; 13: 385-8.
22. Lambalk LM, De Wit APM, Wierda JMKH, Hennis PJ, Agoston S. Dose-response relationship and time course of action of Org 9426. Anaesthesia 1991; 46: 907-11.
23. Feldman S, Khaw K. The effect of dose and rate of stimulation on the action of rocuronium. European Journal of Anaesthesiology 1995; 12: 11-3.
24. Feldman SA. Monitoring neuromuscular conduction. In: Feldman SA, ed. Neuromuscular Block. Oxford: Butterworth-Heinemann, 1996: 141-50.
25. England AJ, Richards KM, Feldman SA. The effect of rate of stimulation on force of contraction in a partially paralysed rat phrenic nerve hemidiaphragm preparations. Anesthesia and Analgesia, in press.
26. Findley GP, Spittal MJ. Rocuronium pretreatment reduces suxamethonium induced myalgia: a comparison with vecuronium. British Journal of Anaesthesia 1996; 76: 526-9.
27. Norman J. Neuromuscular blocking agents of the future. In: Bowman WC, Denissen PAF, Feldman S, eds. Neuromuscular Blocking Agents: Past, Present and Future. Amsterdam: Excerpta Medica, 1990: 15-9.